Xia L - Search Results

1

Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.

Chen Y, Lu J, Xia L, Xue D, Yu X, Shen D, Xu L, Li G. Chen Y, et al. Among authors: xia l. Cancer Sci. 2018 Feb;109(2):384-394. doi: 10.1111/cas.13461. Cancer Sci. 2018. PMID: 29197138 Free PMC article.

2

TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.

Ding X, Yang DR, Lee SO, Chen YL, Xia L, Lin SJ, Yu S, Niu YJ, Li G, Chang C. Ding X, et al. Among authors: xia l. Int J Cancer. 2015 Feb 15;136(4):955-64. doi: 10.1002/ijc.29049. Epub 2014 Jul 14. Int J Cancer. 2015. PMID: 24975468

3

Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.

Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, Wang M, Li G, Chang C. Ding X, et al. Among authors: xia l. Mol Cancer. 2015 Jan 27;14(1):16. doi: 10.1186/s12943-014-0281-1. Mol Cancer. 2015. PMID: 25623427 Free PMC article.

4

Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.

Yu S, Wang M, Ding X, Xia L, Chen B, Chen Y, Zhang Z, Niu Y, Li G, Chang C. Yu S, et al. Among authors: xia l. Prostate. 2015 Oct;75(14):1632-42. doi: 10.1002/pros.23044. Epub 2015 Jul 14. Prostate. 2015. PMID: 26178291

5

Drug Resistance of Enzalutamide in CRPC.

Chen X, Lu J, Xia L, Li G. Chen X, et al. Among authors: xia l. Curr Drug Targets. 2018;19(6):613-620. doi: 10.2174/1389450118666170417144250. Curr Drug Targets. 2018. PMID: 28413979 Review.

6

Identification of novel genetic etiology and key molecular pathways for seminoma via network-based studies.

Chen Y, Qi C, Xia L, Li G. Chen Y, et al. Among authors: xia l. Int J Oncol. 2017 Oct;51(4):1280-1290. doi: 10.3892/ijo.2017.4092. Epub 2017 Aug 4. Int J Oncol. 2017. PMID: 28791339

7

A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.

Chen YL, Ge GJ, Qi C, Wang H, Wang HL, Li LY, Li GH, Xia LQ. Chen YL, et al. J Cell Physiol. 2018 Oct;233(10):6649-6660. doi: 10.1002/jcp.26441. Epub 2018 Apr 25. J Cell Physiol. 2018. PMID: 29327492

8

Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers.

Shen D, Yu X, Wu Y, Chen Y, Li G, Cheng F, Xia L. Shen D, et al. Among authors: xia l. Expert Rev Anticancer Ther. 2018 May;18(5):487-499. doi: 10.1080/14737140.2018.1449648. Epub 2018 Mar 20. Expert Rev Anticancer Ther. 2018. PMID: 29521139 Review.

9

Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals.

Xue D, Wang H, Chen Y, Shen D, Lu J, Wang M, Zebibula A, Xu L, Wu H, Li G, Xia L. Xue D, et al. Among authors: xia l. Mol Cancer. 2019 Nov 1;18(1):151. doi: 10.1186/s12943-019-1072-5. Mol Cancer. 2019. PMID: 31672157 Free PMC article.

10

Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.

Chen Y, Jiang S, Lu Z, Xue D, Xia L, Lu J, Wang H, Xu L, Li L, Li G. Chen Y, et al. Among authors: xia l. J Cell Mol Med. 2020 Jan;24(2):1245-1255. doi: 10.1111/jcmm.14748. Epub 2019 Nov 29. J Cell Mol Med. 2020. PMID: 31782902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,804 results

Search Page

Filters